Results · Apr-Jun 2026
Syncom Formulations (India) Q1 FY27 results
Sales grew 7% to ₹126 crore from ₹117 crore in Apr-Jun 2025.
Operating profit grew 66% to ₹26.2 crore, an operating margin of 20.9% (up 7.4 points from a year ago).
Net profit grew 58% to ₹24.8 crore from ₹15.8 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −7%, net profit −1%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 125.5 | 116.9 | +7% |
| Operating profit (EBITDA) | 26.2 | 15.8 | +66% |
| Operating margin | 20.9% | 13.5% | +7.4 pts |
| Net profit | 24.8 | 15.8 | +58% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.